EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Hepatocellular Carcinoma in Korea between 2012 and 2014: an Analysis of Data from the Korean Nationwide Cancer Registry

Young Eun Chon iD, Han Ah Lee, Jun Sik Yoon, Jun Yong Park, Bo Hyun Kim, In Joon Lee, Suk Kyun Hong, Dong Hyeon Lee, Hyun-Joo Kong, Eunyang Kim, Young-Joo Won, Jeong-Hoon Lee iD

Journal of Liver Cancer · 30.09.2020 · 20 (2) · 135-147

DOI: 10.17998/jlc.20.2.135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Liver Cancer, erschienen am 30.09.2020. Verfasst von Young Eun Chon und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Korea. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korean Liver Cancer Association Research Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims: Considering the high prevalence and mortality of hepatocellular carcinoma (HCC) in Korea, accurate statistics for HCC are important. We evaluated the characteristics of Korean patients with newly diagnosed HCC.

Methods

We retrospectively evaluated data from the Korean Primary Liver Cancer Registry (KPLCR). The baseline characteristics, treatment modalities, and overall survival (OS) of 4,572 patients with HCC registered in the KPLCR between 2012 and 2014 were investigated.

Results

At the time of HCC diagnosis, the median age was 60.0 years, with male predominance (79.6%). Hepatitis B virus infection was the most common etiology (59.1%). The rates of Barcelona Clinic Liver Cancer (BCLC) stages 0, A, B, C, and D at diagnosis were 3.9%, 36.9%, 12.5%, 39.4%, and 7.3%, respectively. The proportion of very early or early stage HCC at diagnosis (BCLC stage 0 or A) in the 2012-2014 cohort was significantly lower than that in the 2008-2011 cohort (40.8% vs. 48.3%, P

Schlagwörter

Stichwörter der Autor:innen

EpidemiologyHepatitis BHepatocellular carcinomaKoreaSurvival

Autor:innen und Institutionen

  • Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Korea.
  • Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
  • Department of Internal Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea.
  • Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
  • Center for Liver Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
  • Department of Radiology, National Cancer Center, Goyang, Korea.

ORCID-Profile: Young Eun Chon, Jeong-Hoon Lee

Förderung

  • Korean Liver Cancer Association Research Award

Zitieren

APA

Chon, Y. E., Lee, H. A., Yoon, J. S., Park, J. Y., Kim, B. H., Lee, I. J., Hong, S. K., Lee, D. H., Kong, H. J., Kim, E., Won, Y. J., & Lee, J. H. (2020). Hepatocellular Carcinoma in Korea between 2012 and 2014: an Analysis of Data from the Korean Nationwide Cancer Registry. Journal of Liver Cancer, 20(2), 135-147. https://doi.org/10.17998/jlc.20.2.135

Vancouver

Chon YE, Lee HA, Yoon JS, Park JY, Kim BH, Lee IJ, et al. Hepatocellular Carcinoma in Korea between 2012 and 2014: an Analysis of Data from the Korean Nationwide Cancer Registry. Journal of Liver Cancer. 2020;20(2):135-147. doi:10.17998/jlc.20.2.135

BibTeX
@article{Chon2020,
  author = {Chon, Young Eun and Lee, Han Ah and Yoon, Jun Sik and Park, Jun Yong and Kim, Bo Hyun and Lee, In Joon and Hong, Suk Kyun and Lee, Dong Hyeon and Kong, Hyun-Joo and Kim, Eunyang and Won, Young-Joo and Lee, Jeong-Hoon},
  title = {Hepatocellular Carcinoma in Korea between 2012 and 2014: an Analysis of Data from the Korean Nationwide Cancer Registry},
  journal = {Journal of Liver Cancer},
  year = {2020},
  volume = {20},
  number = {2},
  pages = {135--147},
  doi = {10.17998/jlc.20.2.135}
}
Kostenlos starten →